Volker Knappertz's Net Worth
$4.83 Million
Who is Volker Knappertz?
Volker Knappertz has an estimated net worth of $4.83 Million. This is based on reported shares across multiple companies, which include GW PHARMACEUTICALS PLC, and Aurinia Pharmaceuticals Inc..
SEC CIK
Volker Knappertz's CIK is 0001754122
Past Insider Trading and Trends
2019 was Volker Knappertz's most active year for acquiring shares with 8 total transactions. Volker Knappertz's most active month to acquire stocks was the month of February. 2021 was Volker Knappertz's most active year for disposing of shares, totalling 20 transactions. Volker Knappertz's most active month to dispose stocks was the month of April. 2021 saw Volker Knappertz paying a total of $179.01 for 252,156 shares, this is the most they've acquired in one year. In 2021 Volker Knappertz cashed out on 1,032,144 shares for a total of $1,026,141.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GW PHARMACEUTICALS PLC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -92.41K |
—
|
—
|
0
|
May 5
| |||
Form 4
| -3.21% | -3.06K |
$18.10 | -$55,386.00 | 92.41K |
Mar 26
| |||
Form 4
| +432.17% | 77.53K |
$17.90 | -$900,556.60 | 95.47K |
Feb 26 - Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| -25.06% | -6.00K |
$11.67 | -$70,020.00 | 17.94K |
Scheduled
|
Jan 19
| ||
Form 4
| -33.39% | -12.00K |
$10.50 | -$126,000.00 | 23.94K |
Scheduled
|
Nov 24
| ||
Form 4
| -14.31% | -6.00K |
$10.00 | -$60,000.00 | 35.94K |
Scheduled
|
Nov 11
| ||
Form 4
| -12.52% | -6.00K |
$9.17 | -$55,020.00 | 41.94K |
Scheduled
|
Nov 4
| ||
Form 4
| -11.12% | -6.00K |
$11.11 | -$66,660.00 | 47.94K |
Scheduled
|
Aug 4
| ||
Form 4
| -10.01% | -6.00K |
$11.42 | -$68,520.00 | 53.94K |
Scheduled
|
Jul 20
| ||
Form 4
| -27.11% | -22.30K |
$11.17 | -$249,150.48 | 59.94K |
Scheduled
|
May 15 - Jun 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +117.31% | 121.88K |
$9.67 | -$113,326.78 | 225.78K |
May 18
| |||
Form 4
| -4.13% | -3.42K |
$8.32 | -$28,454.40 | 79.39K |
Mar 2
| |||
Form 4
| -3.51% | -3.01K |
$9.18 | -$27,636.24 | 82.81K |
Feb 26
| |||
Form 4
|
—
|
0
|
$14.64 | -$177,829.97 | 85.82K |
May 18 - May 20
| |||
Form 4
| -29.93% | -3.73K |
$14.46 | -$53,964.72 | 8.74K |
Mar 1
| |||
Form 4
| +52.57% | 4.3K |
$12.46 | -$51,557.23 | 12.47K |
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aurinia Pharmaceuticals Inc. (AUPH) Snapshot price: $7.9199
EVP, Research and Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.52% | -4.93K |
$6.10 | -$30,073.00 | 319.13K |
Feb 27
| |||
Form 4
| -7.20% | -25.15K |
$5.48 | -$137,800.08 | 324.06K |
Feb 20
| |||
Form 4
| +125.29% | 191.46K |
—
|
—
| 344.27K |
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||